CytoSorbents Sponsors the German Sepsis Society and Sepsis Heroes in Honor of World Sepsis Day
MONMOUTH JUNCTION, N.J., Sept. 7, 2012 -- MONMOUTH JUNCTION, N.J., Sept. 7, 2012 /PRNewswire/ -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to modulate the immune system, reduce severe inflammation, and fight organ failure caused by life-threatening illnesses such as sepsis, announced that it has become a member and sponsor of the Germany Sepsis Society and a sponsor of the Sepsis Heroes Evening, hosted by the Sepsis Alliance, in honor of the first World Sepsis Day on September 13, 2012.
Professor Konrad Reinhart, Chairman of the Board of the Global Sepsis Alliance and Founding President of the German Sepsis Society, stated, "We are happy that such innovative young companies are joining our common effort to find a therapy and solutions for this huge medical and societal problem."
Dr. Phillip Chan, Chief Executive Officer, commented, "We are proud to support these outstanding organizations and to be part of the global effort to create greater awareness of sepsis – a terrible illness that claims the lives of millions of people across the world each year. Often, sepsis is recognized too late because patients don't know what it is and what to look out for, resulting in uncontrolled inflammation, organ failure and death. This is why increasing public awareness is so important. Faster recognition of sepsis and better therapies can save lives. We hope that CytoSorb®, a blood filter approved in the European Union to reduce cytokines that cause excessive inflammation in sepsis, will help tip the scale towards survival in this major unmet medical need."
About the German Sepsis Society
The German Sepsis Society (GSS) is the primary medical society in Germany whose mission is to educate and increase public and professional awareness about sepsis. The organization brings together leaders in sepsis research, diagnostics, treatment, and education in order to also encourage new research, recognize valuable scientific contributions, and foster collaborations to help save lives. A major goal is to support the rapid implementation of effective sepsis diagnostics and therapies into the standard of care treatment for sepsis. Members of the GSS have been heavily involved with SepNet, or the Sepsis Competence Network, a consortium of hospitals and investigators funded for 10 years by the German Federal Ministry of Education to conduct research and clinical trials in sepsis. The GSS also initiated the foundation of the organization, German Sepsis Aid, by people who survived sepsis and their relatives, to provide assistance, information, and networking for those whose lives have been touched by sepsis.